CD57+ GRZB+ EMRA CD8+ T cell proportion

1. Chemotherapy is associated with CD57+ GRZB+ EMRA CD8+ T cell proportion in humans.

   “Chemotherapy prior to anti-PD-1/PD-L1 was associated with an increased proportion of CD57+ EMRA CD8+ T cells (p = 0.009) and its granzyme B (GRZB) subset (p = 0.007).”

   Humanscancer; assessed before anti-PD-1/PD-L1 therapyn = 35

   CD57⁺ EMRA CD8⁺ T cells in cancer patients over 70: associations with prior chemotherapy and response to anti-PD-1/PD-L1 therapy

   Immunity & ageing : I & A·27 Dec 2024

More on Chemotherapy